Cefodizime in Skin Suction Blister Fluid and Serum Following a Single Intravenous or Intramuscular Dose in Adult Patients

REFERENCES

• Periti P, Mazzei T, Mini E, Novelli A. Attualita delle cefalosporine in chemioterapia. Firenze: Edizioni Riviste Scientifiche (E.R.S.), 1988.
   Google Scholar
• Periti P, Mazzei T, Mini E, Novelli A. Polarita delle beta-lattamine e prerogative antibiotiche: razionale di una classifi-cazione chimica. Farm Ter 1993; X: 63-69.
   Google Scholar
• Periti P, Mazzei T, Mini E, Novelli A. Classificazione delle betalattamine cefemiche: le multipolari ioniche nello sviluppo generazionale. Farm Ter 1993; X: 70-79.
   Google Scholar
• Singh R, Fiakpui C, Galpin J, Stewart J, Singh MP, Micetich RG. Synthesis and structure-activity relationship of C-3 substituted triazolylthiomethyl cephems. Eur J Med Chem 1996; 31: 301–309.
   Web of Science ®Google Scholar
• Bucourt R, Heymes R, Lutz A, Penasse L, Perronnet J. Cephalosporines a chaines amino-2 thiazolyl-4 acetyles. Influence de la presence et de la configuration d'un groupe oxyimino sur l'activite antibacterienne. Tetrahedron 1978; 34: 2233–2243.
   Google Scholar
• Periti P. Cefodizima - Farmacologia clinica e chemioter-apia. Farm Ter 1995; XII: 65-115.
   Google Scholar
• Blumbach J, Dtirckheimer W, Ehlers E, et al. Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. J Antibiot 1987; XL: 29-42.
   Google Scholar
• Arai S, Tabata S, Kobayashi S, Inazu M, Hayashi S. Pharmacokinetic study of cefodizime in experimentally infected animals. Arzneim-Forsch/Drug Res 1989; 39: 877–882.
   PubMed Web of Science ®Google Scholar
• Klesel N, Limbert M, Seeger K, Seibert G, Winkler I, Schrinner E. Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in labo-ratory animals. J Antibiot 1984; XXXVII: 901-909.
   Google Scholar
• Barre J. Pharmacokinetics of cefodizime: a review of the data on file. J Antimicrob Chemother 1990; 26 ( Suppl C): 95-101.
   Google Scholar
• Bryskier A, Procyk T, Labro MT. Cefodizime, a new 2-aminothiazolyl cephalosporin: physicochemical properties, tox-icology and structure-activity relationships. J Antimicrob Chemother 1990a; 26 (Suppl C): 1-8.
   Google Scholar
• Bryskier A, Procyk T, Tremblay D, Lenfant B, Fourtillan JB. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers. J Antimicrob Chemother 1990b; 26 ( Suppl C): 65-70.
   Google Scholar
• Dagrosa E, Hajdü P, Malerczyk V, de Looze S, Seeger K, Grotsch H. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. Clin Therap 1987; 10: 18–31.
   PubMed Web of Science ®Google Scholar
• Lenfant B, Namour F, Logeais C, et al. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers. Antimicrob Agents Chemother 1995; 39: 2037-2041.
   Google Scholar
• Bryskier A, Procyk T, Tremblay D, Lenfant B, Fourtillan JB. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g. J Antimicrob Chemother 1990c; 26 ( Suppl C): 59-63.
   Google Scholar
• Sathirakul K, Suzuki H, Yasuda K, Hanano M, Sugiyama Y. Construction of a physiologically based pharma-cokinetic model to describe the hepatobiliary excretion process of ligands: quantitative estimation of intracellular diffusion. Biol Pharm Bull 1993; 16: 273–279.
   PubMed Web of Science ®Google Scholar
• Sathirakul K, Suzuki H, Yamada T, Hanano M, Sugiyama Y. Multiple transport systems for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 1994; 268: 65–73.
   PubMed Web of Science ®Google Scholar
• Nilsen OG, Rennemo F, Rennemo R, Lenfant B. Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g. J Antimicrob Chemother 1990; 26 ( Suppl C): 71-75.
   Google Scholar
• Veyssier P, Devillers A, Domart Y, Fourtillan JB, Bryskier A, Procyk T. Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairment. J Antimicrob Chemother 1990; 26 ( Suppl C): 77-81.
   Google Scholar
• El Guinaidy MA, Nawishy S, Abd El Bary M, Sabbour MS. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure. Chemotherapy 1991; 37: 77–85.
   Google Scholar
• Conte JE. Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function. J Clin Pharmacol 1994; 34: 1066–1070.
   PubMed Web of Science ®Google Scholar
• Loffreda A, Lampa E, Lucarelli C, et al. Pharmacokinetics of cefodizime in patients with various degrees of renal failure. Chemotherapy 1999; 45: 1–7.
   PubMed Web of Science ®Google Scholar
• Boccazzi A, Fusi G, Mezzopane AM, Maretti M, Careddu P. The pharmacokinetics of cefodizime in children. J Antimicrob Chemother 1990; 26 ( Suppl C): 83-87.
   Google Scholar
• El Touny M, El Guinaidy M, Abdel Bary M, Osman L, Sabbour MS. Pharmacokinetics of cefodizime in patients with liver cirrhosis and ascites. Chemotherapy 1992; 38: 201–205.
   PubMed Web of Science ®Google Scholar
• Mendes P, Lameire N, Rosenkranz B, Malerczyk V, Damm D. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 26 ( Suppl C): 89-93.
   Google Scholar
• Nix DE, Goodwin SD, Peloquin CA, RoteIla DL, Schentag JJ. Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob Agents Chemother 1991; 35: 1947–1952.
   PubMed Web of Science ®Google Scholar
• Carb6n C. Single-dose antibiotic therapy: what has the past taught us? J Clin Pharmacol 1992; 32: 686-691.
   Google Scholar
• Schafer-Korting M, Korting HC, Maag L, Klesel N, Grigoleit H-G, Mutschler E. Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol 1986; 30: 295–298.
   PubMed Web of Science ®Google Scholar
• Barradel LB, Brogden RN. Cefodizime - A review of its antibacterial activity, pharmacokinetic properties and thera-peutic use. Drugs 1992; 44: 800–834.
   PubMed Web of Science ®Google Scholar
• Davies BI, Maesen FPV, van den Bergh JJAM, et al. Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis. Infection 1992; 20 (Suppl 1): S22–S25.
   PubMedGoogle Scholar
• Mazzei T, ToneIli F, Novelli A, et al. Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. Cefotetan tissue penetration. Antimicrob Agents Chemother 1994; 38: 2221–2223.
   PubMed Web of Science ®Google Scholar
• Barza M. Principles of tissue penetration of antibiotics. J Antimicrob Chemother 1981; 8 ( Suppl C): 7-28.
   Google Scholar
• Arai S, Masuyoshi S, Fujimoto K. Distribution of cefodizime to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch. Arzneim-Forsch/Drug Res 1987; 37: 441–444.
   PubMed Web of Science ®Google Scholar
• Korting HC, Schafer-Korting M, Maass L, Klesel N, Mutschler E. Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volun-teers. Antimicrob Agents Chemother 1987; 31: 1822–1825.
   PubMed Web of Science ®Google Scholar
• Vermeer BJ, Reman FC, van Gent CM. The determina-tion of lipids and proteins in suction blister fluid. J Invest Dermatol 1979; 73: 303–305.
   PubMed Web of Science ®Google Scholar
• Allison JH, Bettley FR. Investigations into cantharidine blisters raised on apparently normal skin in normal and abnor-mal subjects. Br J Dermatol 1958: 331–339.
   PubMed Web of Science ®Google Scholar
• Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996; 40: 2703–2709.
   PubMed Web of Science ®Google Scholar
• Kiistala U. Suction blister device for separation of viable dermis from epidermis. J Invest Dermatol 1968; 50: 129–137.
   PubMed Web of Science ®Google Scholar
• Novelli A, Ciuffi M, Reali UM, Mazzei T, Periti P. The suction blister technique as a tool in antimicrobial drug phar-macokinetics. Drug Exptl Clin Res 1983; 9: 555–559.
   Google Scholar
• Stoeckel K, McNamara PJ, Brandt R, Plozza-Nottebrock H, Ziegler WH. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther 1981; 29: 650–657.
   PubMed Web of Science ®Google Scholar
• Pollock AA, Tee PE, Patel IH, Spicehandler J, Simberkoff MS, Rahal JJ-Jr. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother 1982; 22: 816–823.
   PubMed Web of Science ®Google Scholar
• Hyatt jm, McKinnon PS, Zimmer GS, Schentag JJ. The importance of pharmacokinetic/pharmacodynamic surro-gate markers to outcome. Clin Pharmacokinet 1995; 28: 143–160.
   Google Scholar
• Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993; 31 ( Suppl D): 1-16.
   Google Scholar